Royalty Pharma (RPRX)
NASDAQ: RPRX
· Real-Time Price · USD
36.34
-0.16 (-0.44%)
At close: Aug 15, 2025, 3:59 PM
36.08
-0.72%
After-hours: Aug 15, 2025, 07:21 PM EDT
Royalty Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 1.6B | 1.77B | 1.33B | 1.71B | 1.03B | 1.19B | 1.7B | 372.47M | 470.81M | 611.07M | 230.06M | 893.76M | 895.15M | 1.21B | 1.24B | 1.55B | 1.96B | 1.75B |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.67M | 11.47M | 17.26M | 23M | 23M | 23M | 23M | 23M |
Stock-Based Compensation | 1.05M | 2.25M | 2.34M | 2.44M | 2.49M | 2.4M | 2.36M | 2.32M | 2.32M | 2.25M | 2.17M | 2.09M | 2.01M | 2.23M | 2.44M | 2.78M | 3.12M | 6.14M |
Other Working Capital | 743.67M | 8.55M | 60.22M | 42.84M | 29.31M | 13.18M | -1.45M | -8.6M | -5.89M | 1.23M | -1.34M | 7.05M | 9.39M | 4.09M | 17.41M | 19.41M | 51.32M | 2.15M |
Other Non-Cash Items | 118.77M | 911.26M | 1.38B | 1.03B | 1.61B | 1.41B | 1.28B | 2.43B | 2.29B | 2.07B | 1.87B | 1.1B | 1.06B | 739.24M | 767.22M | 544.96M | 123.21M | 316.36M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 744.54M | 18.4M | 53.38M | 49.77M | 31.48M | 19.02M | 5.38M | -17.58M | -11.54M | 29.24M | 32.66M | 53.75M | 21.77M | -23.06M | -16.32M | -31.64M | 26.4M | -7.71M |
Operating Cash Flow | 2.47B | 2.7B | 2.77B | 2.8B | 2.67B | 2.62B | 2.99B | 2.79B | 2.75B | 2.72B | 2.14B | 2.06B | 1.99B | 1.95B | 2.02B | 2.09B | 2.13B | 2.09B |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | -69.37M | -3.98M | -10.96M | -12.95M | -16.93M | -15.93M | -12.54M | -10.55M | -13.41M | -10.43M | -9.9M | -16.43M | -20.48M | -29.19M | -34.85M | -39.21M | -28.32M | -35.73M |
Purchase of Investments | -1.78B | -2.66B | -2.74B | -3.24B | -2.49B | -1.6B | -2.12B | -1.47B | -2.65B | -2.89B | -2.57B | -2.87B | -2.72B | -2.84B | -3.59B | -4.34B | -4.06B | -4.11B |
Sales Maturities Of Investments | 541.49M | 640.06M | 118.36M | 107.22M | 104.33M | 2.88M | 25.83M | 800.2M | 1.01B | 1.28B | 1.55B | 890.08M | 1.32B | 1.63B | 1.78B | 2.25B | 1.88B | 1.53B |
Other Investing Acitivies | -251.55M | -68.02M | -49.32M | -24.95M | -31.98M | 12.04M | 29.44M | 26.82M | 22.37M | 22.37M | n/a | n/a | n/a | -18.08M | -18.08M | -18.08M | -18.08M | 15.08M |
Investing Cash Flow | -1.56B | -2.09B | -2.68B | -3.17B | -2.43B | -1.6B | -2.07B | -657.88M | -1.63B | -1.6B | -1.03B | -2B | -1.42B | -1.26B | -1.87B | -2.15B | -2.23B | -2.6B |
Debt Repayment | n/a | n/a | n/a | n/a | -1B | -1B | -1B | -1B | n/a | n/a | n/a | n/a | 1.27B | 1.27B | 1.27B | 1.27B | -94.77M | -141.87M |
Common Stock Repurchased | -1.15B | -938.43M | -229.65M | -207.24M | -250.32M | -170.32M | -170.32M | -140.12M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | -376.31M | -378.02M | -376.46M | -372.15M | -367.84M | -363.5M | -358.33M | -353.19M | -347.25M | -339.69M | -333.32M | -322.72M | -311.93M | -301.46M | -285.18M | -269.19M | -251.05M | -322.05M |
Other Financial Acitivies | -511.08M | 948.29M | 967.26M | 966.61M | 971.38M | -616.56M | -620.11M | -689.1M | -705.76M | -594.57M | -611.53M | -554.65M | -573.62M | -580.25M | -602.24M | -696.65M | -730.56M | -726.85M |
Financial Cash Flow | -2.04B | -368.16M | 361.14M | 387.21M | -646.77M | -2.15B | -2.15B | -2.18B | -1.05B | -934.26M | -944.86M | -877.38M | 386.98M | 390.82M | 385.11M | 305.79M | -1.09B | 717.98M |
Net Cash Flow | -1.13B | 244.72M | 452.02M | 13.6M | -408.43M | -1.13B | -1.23B | -55.18M | 65.04M | 184.17M | 169.7M | -809.18M | 965.76M | 1.08B | 532.37M | 248.01M | -1.18B | 210.74M |
Free Cash Flow | 2.47B | 2.7B | 2.77B | 2.8B | 2.67B | 2.62B | 2.99B | 2.79B | 2.75B | 2.72B | 2.14B | 2.06B | 1.99B | 1.95B | 2.02B | 2.09B | 2.13B | 2.09B |